Distal enhancers characterized by the H3K4me 1 mark play critical roles in developmental and transcriptional programs. However, potential roles of specific distal regulatory elements in regulating RNA polymerase II (Pol II) promoter-proximal pause release remain poorly investigated. Here, we report that a unique cohort of jumonji C-domain-containing protein 6 (JMJD6) and bromodomain-containing protein 4 (Brd4) cobound distal enhancers, termed antipause enhancers (A-PEs), regulate promoter-proximal pause release of a large subset of transcription units via long-range interactions. Brd4-dependent JMJD6 recruitment on A-PEs mediates erasure of H4R3me 2(s) , which is directly read by 7SK snRNA, and decapping/demethylation of 7SK snRNA, ensuring the dismissal of the 7SK snRNA/HEXIM inhibitory complex. The interactions of both JMJD6 and Brd4 with the P-TEFb complex permit its activation and pause release of regulated coding genes. The functions of JMJD6/ Brd4-associated dual histone and RNA demethylase activity on anti-pause enhancers have intriguing implications for these proteins in development, homeostasis, and disease.
INTRODUCTION
The critical roles of enhancers have been recognized for more than 25 years, and recently the H3K4me 1 mark was identified to characterize many gene enhancers (Heintzman et al., 2009 ). These enhancers have been recently found to be usually associated with noncoding RNA transcripts called enhancer RNA (Hah et al., 2013; Lam et al., 2013; Li et al., 2013; Natoli and Andrau, 2012; Ren, 2010) . The molecular mechanisms underlying transcription regulation by enhancers as well as other distal regulatory elements with enhancer-like properties remain incompletely understood. JMJD6, also known as PTDSR or PSR, a JmjC-domaincontaining protein, has been suggested to possess novel, unexpected nuclear functions (Cui et al., 2004; Tibrewal et al., 2007) . Ablation of JMJD6 in mice caused abnormal development and led to neonatal lethality (Bö se et al., 2004; Kunisaki et al., 2004; Li et al., 2003) . It was originally identified as a phosphatidylserine receptor on the surface of phagocytes (Fadok et al., 2000) . It has been recently reported to be an arginine demethylase and lysyl-5-hydroxylase (Chang et al., 2007; Webby et al., 2009) , although the potential functional importance of these activities remains unclear. Meanwhile, a structural study suggested that methyl groups on single-stranded RNAs (ssRNAs) might be substrates of JMJD6 (Hong et al., 2010) .
Brd4, along with Brd2, Brd3, and testes/oocyte-specific BrdT, comprises the BET domain family of proteins in mammals, which is characterized by the presence of tandem, amino-terminal bromodomains and an extraterminal (ET) domain. Knockout of Brd4 and Brd2 in mice leads to early embryonic lethality (Gyuris et al., 2009; Houzelstein et al., 2002) . Small-molecule inhibition of Brd4 has been proposed as a promising therapeutic strategy for certain cancers (Delmore et al., 2011; Filippakopoulos et al., 2010; Nicodeme et al., 2010; Zuber et al., 2011) . Brd4 has been found in several complexes, including the mediator and P-TEFb complexes Wu et al., 2003; Yang et al., 2005) . The P-TEFb complex is a heterodimer consisting of the cyclin-dependent kinase Cdk9 and a cyclin component (Cyclin T1, T2, or K) . Brd4 is capable of releasing the P-TEFb complex from the inhibitory factors, HEXIM1/2 and 7SK snRNA, through its direct interaction with Cyclin T1, resulting in the transition of the P-TEFb complex from its inactive to an active form and subsequent phosphorylation of RNA Pol II, leading to efficient transcriptional elongation Yang et al., 2005) . This positive regulation of the P-TEFb complex is believed to be vital for Brd4 function (Dey et al., 2009; Hargreaves et al., 2009; Mochizuki et al., 2008; Yang et al., 2008) . Enhancer-bound Brd4 regulation of transcription has been recently shown in cancer cells as well as heart failure, although the underlying molecular mechanisms are incompletely understood (Anand et al., 2013; Lové n et al., 2013) .
Emerging evidence suggests that promoter-proximal pausing of Pol II is a critical regulatory event subsequent to Pol II initiation on a large set of genes (Adelman and Lis, 2012) . Pol II promoterproximal pause release is achieved mainly through the action of the P-TEFb complex, which phosphorylates at least three targets including the NelfE subunit of NELF, the Spt5 subunit of DSIF, and serine 2 of RNA Pol II carboxyl-terminal domain (CTD) (Kim and Sharp, 2001; Marshall et al., 1996; Wada et al., 1998; Yamada et al., 2006) . Half of the total P-TEFb in the cells is reversibly bound to the inhibitory subunit composed of 7SK snRNA and HEXIM1/2 and thus is in an inactive form (Nguyen et al., 2001; Yang et al., 2001) , whereas the remaining half associates with Brd4 Yang et al., 2005) . Although HIV-1 Tat and Brd4 are capable of directly extracting P-TEFb out from its 7SK snRNP inhibitory complex (Krueger et al., 2010) , the physiological molecular mechanisms governing the release of P-TEFb complex and transition to the active form remain incompletely understood.
In the present study, we provide evidence that JMJD6 and Brd4 physically and functionally interact in the context of the active P-TEFb complex to regulate Pol II promoter-proximal pause release of a large cohort of genes. The pause release function of the JMJD6 and Brd4 complex on these genes is established primarily based on binding to distal enhancers, which we term as anti-pause enhancers (A-PEs). Mechanistically, 7SK snRNA is found to function as a ''reader'' for H4R3me 2(s) , a repressive histone mark, and JMJD6 displays dual demethylase activities toward both H4R3me 2(s) and the methyl-cap of 7SK snRNA, resulting in the disassembly of the 7SK snRNA/ HEXIM1 inhibitory complex imposed on the P-TEFb complex. Simultaneously, both JMJD6 and Brd4 are capable of retaining the P-TEFb complex through physical interaction with CDK9 and Cyclin T1, respectively, leading to its activation, and eventuating in transcriptional pause release and gene activation.
RESULTS

Physical and Functional Interaction between JMJD6 and Brd4
Initially, identifying JMJD6 interacting partners in HEK293 cell lines revealed the presence of Brd4, with six peptides predicted with high confidence ( Figure 1A and Table S1 available online), consistent with previous reports (Rahman et al., 2011; Webby et al., 2009 ). Accordingly, JMJD6 was found in the list of Brd4-associated proteins, with four peptides predicted with high confidence, strengthening the possibility that these two proteins might function together to regulate cellular process ( Figure S1A ). In addition, known functional partners of Brd4 were also successfully identified in our pull-down, including the P-TEFb complex composed of Cdk9 and Cyclin T1 Rahman et al., 2011) . The interaction between JMJD6 and Brd4 or P-TEFb complex, including Cdk9 and Cyclin T1/2, was further confirmed, suggesting that it associates with the active form of P-TEFb complex ( Figure 1B ). To test whether JMJD6 also associates with the inactive form of the P-TEFb complex, proteins associated with 7SK snRNA were identified. Known 7SK snRNA-associated proteins, including HEXIM1, BCDIN3, LARP7, and the P-TEFb complex (Cdk9 and Cyclin T1), were successfully identified, whereas neither JMJD6 nor Brd4 was detected (Table S2) , as further confirmed through immunoblotting ( Figure 1C ). These data suggest that JMJD6 and Brd4 specifically interact with the active form of the P-TEFb complex.
Direct interaction between JMJD6 and Brd4 was demonstrated in vitro ( Figures 1D and S1B ) and in HEK293T cells cotransfected with JMJD6 and Brd4 ( Figure 1E ). The JMJD6 interacting domain in Brd4 was mapped to a fragment harboring the extraterminal domain (ET) (aa 471-730) in vitro (Figures S1C-S1E) and in HEK293T cells ( Figure S1F) . Similarly, the aminoterminal and JmjC domains of JMJD6 together mediated its interaction with Brd4 both in vitro (Figures S1G-S1L) and in HEK293T cells ( Figure S1M ).
To begin to examine the transcriptional regulation by JMJD6 and Brd4 in the context of active P-TEFb complex, HEK293T cells were transfected with control small interfering RNA (siRNA) or two independent siRNAs specifically targeting JMJD6 or Brd4 followed by Gro-seq analyses (Figures 1F, S2A, and S2B) . Each of the two siRNAs targeting JMJD6 or Brd4 caused transcriptional changes in a substantial number of genes ( Figures 1G, 1H , S2C, and S2D). We subsequently focused on the conserved program ( Figures 1G and 1H ). In accord with their association with the active P-TEFb complex, 82% of JMJD6-or 71% Brd4-regulated genes exhibited impaired transcription when knocking down of JMJD6 or Brd4, respectively ( Figures 1G and 1H) . Significantly, over 56% or 47% of the genes regulated by JMJD6 or Brd4, respectively, were jointly regulated by these two proteins (n = 1,201) ( Figure 1I and Table S3 ), 96.2% of which were regulated in the same direction by both proteins (n = 1,155) ( Figure 1J ). Out of these 1,155 genes, 88% of them required both JMJD6 and Brd4 for transcriptional activation (n = 1,022) ( Figure 1J ), as further validated by quantitative RT-PCR (qRT-PCR) ( Figure S2E ). These genes that were positively regulated in common by both JMJD6 and Brd4 (n = 1,022) were referred to as JB genes. Gene ontology analysis revealed that functional terms, including cellular metabolic process, embryonic development, RNA splicing and processing, cell death and apoptosis, cellular localization, and cell-cycle regulation, were enriched (Table S4 ). Together, our experiments argue in favor of a physical and functional interaction between JMJD6 and Brd4.
Regulation of Pol II Promoter-Proximal Pause Release by JMJD6 and Brd4 Brd4 has been shown to be critical for transcriptional elongation presumably through its recruitment of P-TEFb complex. Based on the fact that JMJD6 and Brd4 coregulated a significant subset of genes, we hypothesized that JMJD6 might also play a role in the process of P-TEFb activation and promoter-proximal Pol II pause release. To test this hypothesis, Pol II chromatin immunoprecipitation sequencing (ChIP-seq) analysis was performed in control siRNA or siRNA specifically targeting JMJD6-or Brd4-transfected HEK293T cells. For the vast majority of genes, Pol II occupancy was at a much higher density at the promoterproximal region compared to gene body ( Figure S2F ). We then calculated the relative ratio of Pol II density in the promoter-proximal region and the gene body, which has been termed as traveling ratio (TR) (Reppas et al., 2006) or pausing index (Zeitlinger et al., 2007) (Figure 2A ). It was found that nearly 90% of Pol-IIbound genes have a TR larger than 2, suggesting that these genes experience promoter-proximal pausing regulation (Figure S2G) , a result similar to what was found in embryonic stem (ES) cells . When all Pol-II-bound genes were assessed, JMJD6 exhibited only a modest, although significant, effects on TR values, whereas the number of genes and the magnitude of TR changes affected by Brd4 knockdown was much larger (Figures 2B and 2C) . However, when considering only JB genes, we found that knockdown of either protein led to a significant increase of TR values and the changes were in a similar extent, suggesting that these factors coregulate Pol II promoter-proximal pause release on these genes ( Figures 2D  and 2E) . Furthermore, the significance of the TR change caused by JMJD6 or Brd4 knockdown was comparable to that by DRB or flavopiridol treatment, two P-TEFb inhibitors (Figures S2H and S2I) . Specifically, $85% of those 1,022 genes showed an increase of TR value after knocking down either JMJD6 or Brd4 ( Figure S2J ). The fold change of TR value on a specific gene correlated poorly with its length (Figures S2K and S2L) . To further strengthen the idea that both JMJD6 and Brd4 are essential and function in a protein complex to regulate pause release of JB genes, double knockdown of JMJD6 and Brd4 displayed no additive effects on TR change compared to knockdown of JMJD6 or Brd4 individually ( Figure S2M ).
In further support of their role in promoting Pol II promoterproximal pause release, knockdown of JMJD6 or Brd4 caused a slight increase of read density at promoter-proximal region but a dramatic decrease along the gene body based on Groseq analysis, resembling a typical pause release defect (Figure 2F) . By the criterion defining Pol II TR as the relative ratio of Gro-seq reads density in the promoter-proximal region and the gene body, both JMJD6 and Brd4 knockdown caused a significantly increased TR compared to control samples when all Pol-II-bound genes were examined, with the magnitude of TR changes caused by Brd4 knockdown being more dramatic (Figures 2G and 2H) . Importantly, $85% of those 1,022 genes showed an increase of TR value after knocking down either JMJD6 or Brd4 ( Figures 2I, 2J , and S2N). Similar to analyses based on Pol II ChIP-seq, the fold change of TR value assessed by Gro-seq on a specific gene was poorly correlated with its length ( Figures S2O and S2P ). 
Genomic Localization of JMJD6 and Brd4
ChIP-seq profiling of JMJD6 and Brd4 binding sites across the genome revealed that Brd4 localized on the promoter region of a large set of genes (n = 6,120, $44% of its total binding sites), with the remaining 56% (n = 7,878) located on intergenic and intragenic regions ( Figure 3A ). In contrast, JMJD6 was detected on only $500 promoters, comprising $6% of all JMJD6 binding sites, with the vast majority of JMJD6 binding sites (n = 7,815) located on intergenic and intragenic regions (Figures 3B and S3A) . Identified binding sites for JMJD6 and Brd4 were validated by ChIP-qPCR ( Figure S3B ). Interestingly, JMJD6 and Brd4 were highly correlated on distal regions (intergenic and intragenic regions) ( Figures 3C and S3C ). Although Brd4 promoter occupancy was observed on $53% of those JB genes, only $3% of them (n = 34) had detectable peaks for JMJD6 ( Figure 3D ). Indeed, the ChIP-seq tag density for JMJD6 was close to background at the promoter regions of those JB genes ( Figures 3E  and 3F ). These observations raised the intriguing possibility that JMJD6, with Brd4, might regulate Pol II promoter-proximal pause release for the subset of genes they jointly regulated in an unexpected distal regulatory fashion, which would be most likely established via long-range interactions between promoters and JMJD6 and Brd4 co-occupied distal sites ( Figure 7K ).
Characterization of JMJD6 and Brd4 Co-Occupied Distal Sites
To test whether JMJD6 and Brd4 cobound distal sites might correspond to current definitions of enhancers, we performed ChIP-seq for several histone marks and coactivators, finding that they were enriched with H3K4me 1/2 , H3K27Ac, and P300 but exhibited low/no levels of H3K4me 3 , features characteristic of active enhancers ( Figures 3E and 3F ). We hypothesized that Brd4 recognition of acetylated histones was likely to account for the recruitment of the Brd4 and JMJD6 complex to their co-occupied enhancers because the two bromodomains of Brd4 are well established to bind to acetylated histone tails, mainly focusing on diacetylated H3 (K9 and K14) (H3Ac) or tetraacetylated H4 (K5, 8, 12, and 16) (H4Ac). Indeed, $95% of Brd4 binding regions and $90% of JMJD6 and Brd4 cobound distal enhancers were enriched with either H3Ac or H4Ac marks ( Figures S3D, S3E , and 3E-3G). To support the requirement of Brd4 for JMJD6 binding, it was found that JMJD6 binding decreased significantly following knockdown of Brd4 on randomly selected JMJD6 and Brd4 cobound distal enhancers ( Figure 3H) ; however, knockdown of JMJD6 exerted no significant effects on Brd4 binding ( Figure 3I ).
H4R3me 2(s) Demethylase Activity of JMJD6
To explore how the recruitment of the JMJD6 and Brd4 protein complex to their co-occupied distal enhancers functionally links to the regulation of Pol II promoter-proximal pause release, we first examined JMJD6 histone demethylase activity. It was found that, in contrast to the enzymatically dead mutant, wild-type JMJD6 purified from bacterial cells specifically demethylated methylated histone H4R3, including mono-(H4R3me 1 ), symmet-
), and asymmetric di-(H4R3me 2(a) ) forms, but not other methylated arginine or lysine residues examined. Total levels of histone H3 and H4 remained unchanged ( Figures 4A,   S3F , and S3G). An interacting ssRNA (Hong et al., 2010) , its sense or antisense form, was included in our demethylase assay, finding that it exerted no effects on JMJD6 enzymatic activity ( Figure 4A ). To examine JMJD6 regulation by posttranslational modifications (PTMs) or functionally associated protein partners, we performed in vitro histone demethylase assays by using Flagtagged JMJD6 or its enzymatically dead mutant (H187A) purified from HEK293T cells following overexpression. Again, JMJD6 displayed a specific demethylase activity toward H4R3me, but not H4K20me or other arginine or lysine methylations examined. In contrast, the enzymatically dead JMJD6 mutant (H187A) had no effect on any histone modifications examined (Figures 4B  and S3H ; data not shown). RNaseA was also included in the demethylation reactions to remove any RNA copurified with the enzyme, finding that it had no effect on JMJD6 enzymatic activities ( Figure 4B ). Furthermore, JMJD6 demethylase activity toward H4R3me was confirmed using histone tail peptides as substrates ( Figure S3I ).
As H4R3me 2(s) and its methyltransferase, PRMT5, have been suggested to associate with transcriptional repression, we focused on the demethylase activity of JMJD6 toward this histone mark in this current study (Wysocka et al., 2006; Xu et al., 2010) . To further support JMJD6 demethylase activity toward H4R3me 2(s) , a significant change of H4R3me 2(s) occupancy was observed on JMJD6 and Brd4 cobound distal enhancers upon JMJD6 knockdown ( Figures 4C and 4D ), but not on the promoter regions of those JB genes ( Figure 4E ). Because histone modifications exert effects through recruiting ''reader'' proteins or noncoding RNAs (Lachner et al., 2003; Ruthenburg et al., 2007; Yang et al., 2011) , we speculated that JMJD6 demethylation of the repressive H4R3me 2(s) mark, which might be read by 7SK snRNA and HEXIM1/2, would result in the disassembly of the inhibitory complex imposed on P-TEFb complex. Probing MODified Histone Peptide Array with purified HEXIM1 protein revealed no specific binding to modified histone tails (data not shown). Intriguingly, 7SK snRNA was found to associate with several histone peptides on the array, with enrichment of H4R3me 2 , as well as H4K5Ac, H4K8Ac, H4K12Ac, and H4K16Ac modifications ( Figures 4F, S3J , and S3K). In vitro RNA pull-down confirmed that 7SK snRNA specifically associated with nucleosomes enriched for H4R3me 2 or H4Ac (K5, 8, 12, and 16), but not H3R2me 2 or H3Ac (K9 and 14) ( Figure 4G ).
Furthermore, H4R3me
2(s)
-containing histone tails were found to specifically associate with the 5 0 -, but not 3 0 -terminal half of 7SK ( Figures 4H and S3L) . Together, these data suggest that JMJD6-mediated demethylation of H4R3me 2(s)
, a repressive histone mark directly read by 7SK snRNA, can potentially result in the dismissal of 7SK snRNA/HEXIM1 inhibitory complex and subsequent P-TEFb complex activation and transcriptional pause release ( Figure 7K) .
A 7SK snRNA Decapping Function of JMJD6 7SK snRNA is capped posttranscriptionally through the addition of a methyl group directly on the gamma-phosphate of its first 5 0 nucleotide by its capping enzyme, BCDIN3/MePCE (Jeronimo et al., 2007) . The cap structure enhances the stability of 7SK snRNA by protecting the RNA from exonucleolytic degradation (Jeronimo et al., 2007; Shumyatsky et al., 1990) . As a recent (legend continued on next page) structural study suggested that methyl group on ssRNA might serve as substrate of JMJD6 (Hong et al., 2010) , we hypothesized that JMJD6 might possess a novel activity toward the methyl group in the cap structure of 7SK snRNA, which could result in 7SK snRNA destabilization and subsequent P-TEFb activation. Indeed, BCDIN3 efficiently methylated 7SK snRNA, and the methylation signals decreased in a dose-dependent manner in the presence of JMJD6 (Figures 4I and S3M) . Furthermore, demethylation of 7SK snRNA by JMJD6 was dependent on its JmjC domain ( Figure S3N) . Surprisingly, neither JMJD6 nor Brd4 knockdown resulted in a significant change of total 7SK snRNA levels assessed by northern blotting in cells, suggesting JMJD6 demethylation of 7SK snRNA might occur locally on chromatin ( Figure S3O ). 7SK snRNA ChIRP was then performed using a single DNA oligonucleotide, which was shown to specifically target and efficiently pull down 7SK snRNA (Yang et al., 2001) . Indeed, around 85% of total cellular 7SK snRNA was retrieved, but not GAPDH mRNA ( Figure 4J ). Knockdown of BCDIN3 led to a significant decrease of the tags of our identified 7SK binding peaks (p < 10E-100), further supporting specificity of the 7SK ChIRP. Consistent with our hypothesis, 7SK snRNA occupancy increased significantly on JMJD6 and Brd4 cobound distal enhancers following JMJD6 or Brd4 knockdown, but not on the promoter regions of those JB genes ( Figures 4K  and S3P ). Increased HEXIM1 binding was also observed for a number of JMJD6 and Brd4 cobound distal enhancers tested by conventional ChIP ( Figure 4L ). We therefore have coined a presumptive designation for the JMJD6 and Brd4 cobound distal enhancers, referring to them as anti-pause enhancers (A-PEs), on which JMJD6 displays demethylation activity toward H4R3me 2(s) and methyl group in the 7SK snRNA cap.
Anti-Pause Enhancers Loop to and Regulate Pausing Release of Target Gene Promoters
To test the hypothesis that JMJD6 regulation of Pol II promoterproximal pause release would be established via long-range interactions between promoters and anti-pause enhancers (A-PEs), chromosome conformation capture (3C) analysis was performed for a number of genes, which were strongly regulated by JMJD6 and Brd4, including SAMD11, ALDOA, RHOB, CHKB, C16orf93, and TRIM11, all of which showed specific interactions with their nearby cognate A-PEs ( Figures 5A-5C and S4A-S4C). Intriguingly, the detected interactions were generally not significantly affected by either JMJD6 or Brd4, suggesting that they were established based on other enhancer-bound factors, regardless of gene expression status. The striking presence of nine subunits of the mediator complex in our MS analysis for proteins associated with JMJD6, including MED1 (Table S1) , co-occupancy of Brd4 with MED1 on enhancers and promoters in several cancer cell lines, and mediators' roles in functionally connecting enhancers and core promoters of many active genes prompted us to test whether MED1 affects looping formation between gene promoters and A-PEs (Kagey et al., 2010; Lové n et al., 2013) . Indeed, knockdown of MED1 impaired the looping formation for all gene promoters and A-PEs tested ( Figures  5A-5C and S4A-S4C ).
To further demonstrate that A-PEs are functionally linked to transcriptional control of these coding genes, selected promoter regions were cloned with corresponding A-PEs into pGL3 basic luciferase vectors and transfected into HEK293T cells. For all ten constructs tested, the combination of promoter sequence and anti-pause enhancer (P+A-PE) drove the luciferase gene expression efficiently, which was impaired following knockdown of either JMJD6 or Brd4 ( Figures 5D-5F and S4D-S4J, far right three columns). To support the notion that A-PEs regulate transcription at the Pol II promoter-proximal pause release step, Pol II ChIP analysis revealed that the relative ratio of Pol II density in the promoter-proximal region and two selected regions on the luciferase gene body increased significantly following knockdown of JMJD6 or Brd4, suggesting a defect in Pol II pause release ( Figures 5G and 5H) . Interestingly, the luciferase reporter activities detected from vectors containing promoter sequences only (P), presumably lacking of 7SK snRNA/HEXIM inhibitory complex associated with A-PEs, was significantly lower than vectors containing both promoter sequences and A-PEs (P+A-PE), suggesting that JMJD6 and Brd4 might have additional roles, such as retaining the P-TEFb complex, besides their function in dismissing the inhibitory 7SK snRNA/HEXIM complex ( Figures 5D-5F and S4D-S4J). Consistent with this, the relative ratio of Pol II density in the promoter-proximal region and selected region in the body of luciferase gene detected from luciferase vector containing promoter sequence only (P) was significantly larger than that from luciferase vectors containing both promoter sequence and A-PE (P+A-PE) ( Figures 5G and 5H) .
Activation of the P-TEFb Complex by JMJD6 and Brd4
Our data suggested that JMJD6 and Brd4 might retain and activate the P-TEFb complex in addition to dismissing 7SK snRNA/HEXIM. Because Brd4 is known to interact with the Cyclin T1 in the P-TEFb complex and to be capable of extracting the P-TEFb complex from 7SK snRNP Krueger et al., 2010; Yang et al., 2005) , we investigated whether JMJD6 might play a similar role. JMJD6 was found to specifically interact with CDK9, but not with Cyclin T1 (Figures 6A, 6B , and S5A). Both the amino-terminal and the JmjC domain of JMJD6 were able to interact with CDK9, whereas carboxyl-terminal, containing the unstructured region, failed to do so ( Figures  S5B and S5C) . The carboxyl-terminus (aa 315-372) of CDK9 was apparently required for its binding with JMJD6 as any truncations lacking this region failed to bind ( Figure S5D ), but sufficiency could not be tested because it alone was not expressed in cells. Therefore, our data and those from previous studies demonstrated that JMJD6 and Brd4 interact with distinct (H and I) Brd4 is required for JMJD6 binding on chromatin, but not vice versa. Standard ChIP assay was performed with anti-JMJD6 (H) or anti-Brd4 (I) antibody in HEK293T cells. The five regions bound by both JMJD6 and Brd4 tested were selected from Figure S3B . ChIP signals were presented as percentage of inputs (±SEM, ***p < 0.001). (1:chr1:232,701,545-232,701,745; 2:chr4:12,251,121-12,251,321; 3: chr18:2,832,201-2,832,401; 4: chr3:13,664,851-13,665,051; 5: chr7:61,371,401-61,371,601) . See also Figure S3 . Figure S4A ). See also Figure S3 .
subunits in the P-TEFb complex, with JMJD6 interacting with CDK9 and Brd4 with Cyclin T1. Furthermore, CDK9 was directly released from the 7SK/HEXIM snRNP by both JMJD6 (1-305) and Brd4 (1209-1362) (regions binding with the P-TEFb complex) ( Figure 6C ). To support the hypothesis that both JMJD6 and Brd4 are required to efficiently retain and activate the P-TEFb complex, knockdown of either JMJD6 or Brd4 caused a significant decrease of CDK9 occupancy on the promoter regions as well as gene bodies of those JB genes ( Figures 6D-6G and S5F-S5G), whereas the CDK9 protein levels remained unchanged ( Figure 1F ). In accordance with the decrease of CDK9 occupancy, Pol II ser2 phosphorylation decreased significantly across those JB transcription units as well (Figures 6F-6H) . We therefore are tempted to suggest a model in which the dual enzymatic activities of JMJD6 act locally to cause dismissal of the 7SK/HEXIM1 inhibitory complex, and the ability of both JMJD6 and Brd4 to retain P-TEFb leads to subsequent Pol II promoter-proximal pause release ( Figure 7K ). for the release of 7SK/HEXIM1 inhibitory complex imposed on the P-TEFb complex, we would expect to see that knockdown of their corresponding methyltransferases, PRMT5 and BCDIN3/MEPCE, would result in enhanced Pol II promoter-proximal pause release for those JB genes. However, the effect would be expected to be modest due to the fact that these genes are already mostly transcriptionally active. Similar results would also be expected from knocking down the inhibitory components, 7SK snRNA and HEXIM1/2. Knockdown of PRMT5 in HEK293T cells caused a further decrease of H4R3me 2(s) levels on A-PEs ( Figures 7A, S6A , and S6B). To support our hypothesis, we observed a significant, although modest, decrease of Pol II TR after PRMT5 knockdown for JB genes ( Figures 7B and 7J ). Gro-seq-based TR measurement also supported the inhibitory function of PRMT5 in Pol II promoter-proximal pause release ( Figures 7C and 7D ). To further strengthen the idea that JMJD6 and PRMT5 antagonize each other in transcriptional pause release control, double knockdown of these two proteins neutralized the TR changes caused by knocking down of each protein individually ( Figures 7B and 7J) . Together, these data reveal that a dynamic regulation of H4R3me 2(s) specifically occurring at A-PEs, with JMJD6 demethylase activity being dominant, is critical for Pol II promoter-proximal pause control.
We next examined the role of decapping/demethylation of 7SK snRNA on Pol II promoter-proximal pause release by knocking down BCDIN3 followed by Pol II ChIP-seq analysis ( Figures 7E and S6C ). As expected, knockdown of BCDIN3 resulted in a significant decrease of 7SK snRNA level (Figure S6D) . In support of a role of decapping/demethylation of 7SK snRNA on Pol II promoter-proximal pause release, similar to what was observed for PRMT5, BCDIN3 knockdown led to a significant, although modest, decrease of Pol II TR for those JB genes ( Figures 7F and 7J) , which was confirmed by Groseq analysis (Figures 7G and 7H ). Double knockdown of JMJD6 and BCDIN3 neutralized the TR changes caused by knocking down of each protein individually, indicating their antagonistic functions (Figures 7F and 7J) . In contrast, double knockdown of PRMT5 and BCDIN3 caused an additive effect on TR change, suggesting these two proteins function in parallel to regulate pause release for those JB genes ( Figures 7I and 7J) . Finally, based on Pol II ChIP-seq and Gro-seq analyses, both 7SK snRNA and HEXIM1/2 knockdown caused a significant, although modest, decrease of TR, similar to what observed for other inhibitory components, such as PRMT5 and BCDIN3 (Figures S6E-S6R ).
Anti-Pause Enhancers in Other Cell Types
To investigate potential JMJD6 and Brd4 co-occupied antipause enhancers in a second cell line, HeLa cells, Gro-seq experiments were performed, and it was found that JMJD6 and Brd4 coregulated a substantial number of genes (n = 844). Significantly, 96% of these genes required both proteins for activation (n = 814), which we referred as JB genes, representing $83% of the total genes positively regulated by JMJD6 ( Figures  S7A-S7D ). JMJD6 and Brd4 control of Pol II promoter-proximal pause release was readily seen in HeLa cells for those JB genes ( Figures S7E and S7F) . As was the case in HEK293T cells, Brd4 occupied both promoters and distal regions, whereas JMJD6 bound predominately to distal regions in HeLa cells (Figures S7G and S7H) . Importantly, JMJD6 and Brd4 were highly correlated on distal regions ( Figures S7I and S7J ). Only $13% of those JB genes had detectable JMJD6 peaks on their promoter regions, suggesting that JMJD6 regulates Pol II promoter-proximal pause release based on the actions at distal sites ( Figures  S7K and S7L) .
To characterize JMJD6 and Brd4 cobound distal sites (antipause enhancers), we performed ChIP-seq for H3Ac and H4Ac and examined several data sets from the Encode project in HeLa cells. It was found that, similar to our findings in HEK293T cells, JMJD6 and Brd4 cobound distal sites represented active enhancers (enriched with H3K4me 1/2 and H3K27Ac, but exhibiting relatively low levels of H3K4me 3 ) with both H3Ac and H4Ac histone marks ( Figure S7L ). These data suggest that anti-pause enhancer-associated JMJD6 and Brd4 regulation of Pol II promoter-proximal pause release occurs in many cell types.
DISCUSSION
Brd4 and JMJD6 Regulate Promoter-Proximal Pause Release The evidence presented in this manuscript suggests that JMJD6 and Brd4, acting as functional partners, regulate Pol II promoterproximal pausing in a large subset of genes based on their actions on distal enhancers, termed anti-pause enhancers (A-PEs). Mechanistically, it appears that acetylated histone H4/ H3-mediated, Brd4-dependent binding of JMJD6, an enzyme that displays dual demethylase activities toward both histone arginine and the 7SK snRNA cap, on these A-PEs leads to the release of 7SK snRNA/HEXIM1 inhibitory complex imposed on P-TEFb. Meanwhile, both JMJD6 and Brd4 are capable of (D-F) Luciferase reporter activities driven by selected promoter sequences and A-PEs. HEK293T cells were transfected with control luciferase vector, luciferase vector containing promoter sequence only (P), or both promoter sequence and its corresponding nearby A-PE (P+A), followed by luciferase activity measurement. Data were normalized to Renilla internal control (±SEM, *p < 0.05, **p < 0.01, ***p < 0.001).
(legend continued on next page)
extracting and retaining the P-TEFb complex on chromatin, leading to its activation, promoter-proximal Pol II pause release, and gene activation. Brd4 is required for transcriptional activation of a large number of genes, with many of them also requiring JMJD6 for gene activation. However, a large number of genes exhibiting promoterproximal pause regulation by Brd4 are independent of JMJD6 for activation. Indeed, the Brd4 interactome contains other functional partners, such as NSD3, that, whereas not required for the Pol II promoter-proximal pause release of those genes jointly (G and H) Relative ratio of Pol II density in the promoter-proximal region and selected region in the body of luciferase gene. HEK293T cells were transfected with control siRNA or siRNA specifically targeting JMJD6 or Brd4 in the presence of luciferase report vector containing promoter sequence only (P) or both promoter sequence and A-PE (P+A) followed by Pol II ChIP analysis. qPCR was performed with primers as indicated, with primer set F1+R1 targeting promoter region, whereas F2+R2 and F3+R3 targeting two distinct regions on luciferase gene body. Data were presented as relative ratio of Pol II density (±SEM, **p < 0.01, ***p < 0.001). See also Figure S4 . regulated by JMJD6 and Brd4 (data not shown), may function for a distinct cohort of genes, based on binding on either promoter regions or distal enhancers (Rahman et al., 2011) . Similarly, JMJD6 can function independent on Brd4 in promoter-proximal pause release for other transcription units.
JMJD6: Multiple Substrates, Multiple Functions
In the current study, we have focused on the function of JMJD6 demethylase activity on H4R3me 2(s) , a repressive histone mark, in promoting transcriptional pause release. As JMJD6 also exhibited demethylase activity toward H4R3me 2(a) , a histone mark associated with transcriptional activation (Li et al., 2010; Wysocka et al., 2006; Yang et al., 2010) , we envision a role of JMJD6 in gene repression. Indeed, our Gro-seq analysis revealed that a subset of genes was repressed by JMJD6. Whether JMJD6 represses gene transcription based on its H4R3me 2(a) demethylase activity remains as an interesting question for future investigation. Here, we have also uncovered a JMJD6 enzymatic activity targeting RNA methylation, which is specific to the methyl group in the 7SK snRNA cap structure. Testing 
(legend continued on next page)
whether other JmjC-domain-containing proteins target to other types of methylation found on single-stranded RNA (ssRNA) including m 3 U and N 6 A methylation will be of particular interest for future studies. It is noteworthy that JMJD6 demethylase activities toward both H4R3me 2(a) and methyl group in the 7SK snRNA cap structure occur locally on chromatin, suggesting that other demethylases with similar activities might exist, which is also consistent with the fact that, despite being born with severe developmental defects, viable JMJD6 knockout mice could be identified at birth (Bö se et al., 2004; Kunisaki et al., 2004; Li et al., 2003) .
7SK snRNA: A Noncoding RNA Reading Histone Marks Our data support the idea that 7SK snRNA/HEXIM/P-TEFb is tethered to chromatin through 7SK snRNA recognition of the H4R3me 2(s) mark on A-PEs. JMJD6/Brd4 protein complex erasure of H4R3me 2(s) releases 7SK snRNA/HEXIM inhibition, allowing local P-TEFb activation to occur. Reading of other histone marks on chromatin, by 7SK snRNA, may also contribute to its function in transcriptional regulation. Indeed, a specific locked nucleic acid (LNA) targeting 7SK dramatically affects Pol II promoter-proximal pause release and transcription of a large set of genes.
In conclusion, our studies here have revealed anti-pause enhancers regulate Pol II promoter-proximal pause release, on which: (1) JMJD6 and Brd4 binding is detected; (2) there is enrichment of H4Ac and H3Ac marks, as well as classical active enhancer marks; (3) release of 7SK snRNA/HEXIM inhibitory complex occurs, in response to JMJD6 enzymatic activity targeting both H4R3me 2(s) and/or 7SK snRNA cap; and (4) looping is formed with coding gene promoters, providing the apparent architectural basis for their ability to regulate transcriptional pause release events at promoters. A-PEs, therefore, apparently are enhancers with a function in transcriptional pause release, with their unique feature being cobound by both JMJD6 and Brd4, and the associated molecular mechanisms.
EXPERIMENTAL PROCEDURES
siRNA Transfection, RNA Isolation, and qRT-PCR Two independent siRNAs against JMJD6, Brd4, PRMT5, BCDIN3, HEXIM1, or HEXIM2 were used in this study (see Extended Experimental Procedures for siRNA sequence information). Locked nucleic acid (LNA) targeting 7SK snRNA was designed and purchased form Exiqon (G*A*G*A*G*C*T*T*G*T*T*T*G*G*A*G [* = phosphorothioate]). siRNA and LNA transfections were performed using Lipofectamine 2000 (Invitrogen) according to the manufacturer's protocol. Transfection efficiency was determined by immunoblotting and/or qRT-PCR. Total RNA was isolated from HEK293T cells using RNeasy Mini Kit (QIAGEN) following the manufacturer's protocol. First-strand cDNA synthesis from total RNA was carried out using SuperScript III First-strand cDNA synthesis system (Invitrogen). Resulting cDNA was then analyzed by quantitative PCR (qPCR) using Stratagene Mx3000 machine. Primers are specific for genes tested and their sequences are available upon request. All qRT-PCRs were repeated at least three times, and representative results are shown.
Traveling Ratio Calculation
Pol II TR was defined as the relative ratio of Pol II density in the promoterproximal region and the gene body. The promoter proximal region refers to the window from À50 to +300 bp surrounding transcription start site (TSS). Gene body is from 300 bp downstream of TSS to the annotated end. TR calculated based on Gro-seq tag density was defined as ratio of Gro-seq reads density at the promoter-proximal bin (from À50 to +300 bp surrounding TSS) to Gro-seq density at the gene body bin (from +300 bp to the annotated end). The significance of the change of TR between control and knockdown samples was displayed using box plot and determined using Student's t test.
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